WaVe Life Sciences Ltd.


WaVe Life Sciences is a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases. WaVe's chemistry platform enables the creation of highly specific, well characterized oligonucleotides designed to deliver superior efficacy and safety across multiple therapeutic modalities. WaVe's pipeline is initially focused on neurological disorders and extends across several other therapeutic areas.


WaVe Life Sciences was founded by two world-renowned scientific leaders, Gregory Verdine (Harvard University) and Takeshi Wada (Tokyo University of Science), and pursues R&D activities in Boston and Japan.